Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma | Ophthalmology – Stanford Medicine
New research uncovers promising treatment for neurodegenerative diseases like ALS, glaucoma | Ophthalmology Stanford Medicine Source: Author: | Date: 2025-02-20 08:00:00 Source: Author: | Date: 2025-02-20 08:00:00
Telefónica applies 5G and Artificial Intelligence to healthcare with solutions in ophthalmology and oncology – telefonica.com
Telefónica applies 5G and Artificial Intelligence to healthcare with solutions in ophthalmology and oncology telefonica.com Source: Author: | Date: 2025-02-12 08:00:00 Source: Author: | Date: 2025-02-12 08:00:00
CU Ophthalmology Researchers Investigate How Human Breast Milk May Help Heal Cornea Wounds – CU Anschutz newsroom
CU Ophthalmology Researchers Investigate How Human Breast Milk May Help Heal Cornea Wounds CU Anschutz newsroom Source: Author: | Date: 2025-02-06 08:00:00 Source: Author: | Date: 2025-02-06 08:00:00
Evolution of AI in ophthalmology – Healio
Evolution of AI in ophthalmology Healio Source: Author: | Date: 2025-01-09 08:00:00 Source: Author: | Date: 2025-01-09 08:00:00
Machine learning derived retinal pigment score from ophthalmic imaging shows ethnicity is not biology – Nature
Machine learning derived retinal pigment score from ophthalmic imaging shows ethnicity is not biology Nature Source: Author: | Date: 2025-01-02 08:00:00 Source: Author: | Date: 2025-01-02 08:00:00
Peptide Eye Drops Offer Hope for Dry AMD
Researchers from the Natural Product Drug Development Center at the Korea Institute of Science and Technology (KIST), led by Dr. Moon-Hyeong Seo, have developed an innovative therapeutic agent for dry age-related macular degeneration (AMD) in the form of peptide-based eye…
MicroPulse TLT Proven Effective for Glaucoma
Iridex Corporation, a global leader in laser-based medical systems for glaucoma and retinal disease treatment, has announced the publication of a groundbreaking peer-reviewed study in Ophthalmology Therapy. The study provides compelling evidence of the long-term safety and efficacy of MicroPulse…
Galimedix Begins Phase 2 Trial for GAL-101 in Dry AMD
Galimedix Therapeutics has announced the initiation of a phase 2 clinical study called eDREAM (NCT06659549), evaluating the efficacy and safety of GAL-101 eye drops in patients with dry age-related macular degeneration (AMD) and geographic atrophy (GA). About the Phase 2…
Glaukos Submits FDA Application for Epioxa Therapy
Glaukos Corporation has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its innovative corneal cross-linking therapy, Epioxa (Epi-on). This next-generation treatment is designed for patients with keratoconus and represents a significant advancement…
NEI Study Reveals Annexin-V’s Role in Retinal Diseases
A recent study led by the National Eye Institute (NEI) has revealed new insights into annexin-V, a key biomarker traditionally used to track apoptosis (programmed cell death) and retinal cell degeneration in eye diseases. Published in the International Journal of…